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ABSTRACT 
Polycystic ovarian disease is one of the most common gynecological disorders during 
puberty. This is otherwise known as Stein-Leventhal Syndrome and occurs due to the 
incorrect set of hypothalamo-pituitary homeostatic during puberty and characterized by 
oligomenorrhoea / amenorrhoea, delayed periods, hirsutism, hoarseness of voice etc. Based 
on the clinical features this can be compared with Alpartava /Artavakshaya as per the 
Ayurvedic classics. In Artavakshaya (deficiency of Artva), Rajasrava (menstruation) do not 
appear in its appropriate time or is delayed. Often gynecologists keep these patients on 
combination of estrogen and progesterone therapy. Exogenous hormonal treatment again 
disturbs the endogenous hormonal pattern and the pathology continues. In the present 
study an attempt has been made to find out safe alternate therapy to cure PCOD and 
regularize menstruation with Ayurvedic drugs. For the present study, Ashokarishtam is 
selected to improve Rajodhatu, Kanchanara guggulu and Varunadi kashayam are selected to 
regress cysts of the ovary. Study carried out in 52 number of teenage girls, out of which, 21 
(42.86%) patients have shown Good Response, 10 (20.41%) cases have shown Fair 
response, 03 (06.12%) cases have shown Poor response, 15 (32.61%) did not show any 
response and 03 cases were dropped out from the study. On statistical analysis, efficacy of 
the trial drugs found highly significant in relieving PCOD (P<0.001). 
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INTRODUCTION 
Oligomenorrhoea is one of the commonest 
gynecological problems in teenage girls. In 
majority of the cases the reason is polycystic 
ovarian disease otherwise known as Stein-
Leventhal Syndrome. Teenage girls are often 
brought to the Gynecology clinics with the 
complaints of Oligomenorrhoea (Scanty 
menstruation). In some cases it is the reason for 
delayed puberty. In most of the cases the reason 
for scanty menstruation is PCOD, diagnosis of 
which is confirmed on ultra Sonography 
examination. PCOD is the commonest cause for 
ovulatory disorder, has proved to be the most 
difficult to understand and to treat reliably. The 
incidence varies between 0.5 – 4% and is more 
common amongst infertile women[1]. 
 In majority of the cases the onset of 
symptoms is premenarcheal and that pituitary 
feedback mechanisms are grossly intact. These 
vicious cycle of events are due to incorrect set of 
Hypothalamo-pituitary homeostat during puberty. 
Clinical evidence suggests that dysfunction at the 
level of both the pituitary and the ovary in women 
with PCOD may initiate self perpetuating vicious 
cycle of events. Abnormal gonadotrophic secretion 
characterized by over production of luteinizing 
hormone (LH) relative to follicle – stimulating 
hormone induces hyperactivity of ovarian stromal 
tissues, atresia of antral follicles and disordered 
ovarian steroidogenesis. The resulting imbalance 
of oestrogenic and androgenic steroids in turn 
accentuates the hyper secretion of LH by the 
anterior pituitary. Evidences also suggest that 
PCOD is not simply a spontaneous aberration of an 
otherwise normal H-P-O axis but rather that a 
defect exists, which hinders the establishment of 
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normal ovarian control. FSH secretion remains 
either normal or decrease due to negative feed 
back effect of oestrogens and inhibin. Due to 
relative low level of FSH, there is defective ovarian 
folliculogenesis due to lack of aromatization[2]. 
This syndrome is featured with 
amenorrhoea or oligomenorrhoea, delayed and 
irregular periods, hirsutism, hoarseness of voice, 
obesity etc. this complex disorder is characterized 
by excessive androgen production by the ovaries / 
adrenals which interferes with ripening of the 
ovarian follicles[3]. 
Based on the clinical features this 
condition can be compared with Alpartava / 
Artavakshaya as per the Ayurvedic classics. In 
Artavakshaya (deficiency of Artava), Rajasrava 
(menstruation) do not appear in its appropriate 
time or is delayed (intermenstrual period is 
prolonged). Menstrual flow is scanty that means it 
do not lasts for 3-5 days. Artavakshaya 
(Oligomenorrhoea) is the main feature of Vataja 
yonivyapath, Vataja artava dushti, Kshina artava 
dushti, Rajodhatu kshaya etc[4]. In all these cases 
‘vata’ aggravation is the cause. Vata, especially 
Apanavata is the regulating humor of reproductive 
system. It governs the secretions of H-P-O 
responsible for formation of rajas (endometrial 
vascular changes) and Streebija (Ovum). 
Artavakshaya with PCOD can be considered due to 
‘Vidradhi’ in ovaries. Vidradhi is formed due to the 
aggravation of Kapha and Vata dosha.  
Rationale for selection of trial drugs 
Maintenance of normalcy of vata and 
suppression of Kapha are the two main objectives 
in treating PCOD patients with Artavakshaya. And 
at the same time treatment is also necessary to 
enhance the quantity of rajas to maintain normal 
levels. Drugs which are available to enhance rajas 
formation (Emmenagogue) are Ghritakumari, 
Ashoka, Krishnatila, Asthisamhari, Vidarikanda etc. 
Among these Ashoka is Vata, Kapha hara, having 
stimulating effect on endometrium and ovary in 
positive direction to maintain normal 
menstruation[5]. Kanchanara and Guggulu are 
having vata, kapha hara, vranasodhaka, lekhana, 
grandhihara, sothahara properties. Varuna is also 
vata, kapha shamaka, bhedana, gulmahara. Hence 
Kanchanara, Guggulu and Varuna are useful in 
regressing ovarian cysts and bring back normal 
ovarian function[6]. 
 Hence for the present study, 
Ashokarishtam[7] is selected to improve Rajodhatu, 
Kanchanara guggulu[8] and Varunadi kashayam[9] 
are selected to regress cysts of the ovary.  
MATERIAL AND METHODS 
Study carried out in 52 numbers of teenage 
girls, who are having H/o Oligomenorrhoea and 
diagnosed as PCOD based on the evidence of Ultra 
Sonography of pelvis. Cases are recruited into the 
study strictly according to the selection criteria 
and drawn from the OPD of A.L. Research centre 
for Ayurveda, VHS medical campus, Chennai, after 
thorough clinical examination and investigation. 
Study carried out between 2004 and 2008. Out of 
52 cases, three cases were dropped out from the 
study due to irregular follow-up.  
Sample size and methods 
Sample number –  52 
Design of study  –  Open trial 
Number of Groups  –  one 
Drug schedule and Dosage 
1. Kanchanara guggulu – 1gm BD internally for 
three months along with hot water. 
2. Varunadi kashayam – 10ml BD internally for 
three months along with equal water. 
3. Ashokarishtam – 20 ml BD BD internally for 
three months along with equal water. 
Duration of Treatment: 3 months 
Follow up: Once in a month, i.e. at the end of 1st, 
2nd and 3rd months. 
Investigations: Assessment of USG carried out at 
the beginning of treatment and at the end of the 
study. 
Inclusion Criteria 
1. Girl in the Age between 13 – 19 years 
2. PCOD confirmed by USG 
3. With minimum three cycles History of 
Oligomenorrhoea  
Exclusion Criteria 
1. Age below 13 and above 19 years 
2. PCOD associated with any other genital tract 
abnormalities 
3. PCOD with Menorrhagia / Metrorrhagia 
4. Oligomenorrhoea with delayed periods 
5. Suffering with any other Systemic illness 
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Withdrawal Criteria 
1. Irregular treatment and follow up 
2. Any complication arises during treatment 
Criteria for Assessment of Results 
Good Response – Complete disappearance of 
cysts on USG and regular normal menstrual flow 
i.e. bleeding for three days and soakage of two 
pads on first day, one pad on second and third 
days. 
Fair response – Either disappearance of ovarian 
cysts on USG or Restoration of normal menstrual 
flow i.e. bleeding for three days and soakage of two 
pads on first day, one pad on second and third 
days. 
Poor Response – Non –disappearance of cysts, 
but restoration of slightly less than normal 
menstrual flow.  
No Response – No change cysts in the ovary and 
menstrual flow. 
Parameters adapted 
1. Amount of bleeding 
Spotting – One to two inch spot over the 
diaper  
 
20 
Very Scanty - Half diaper on one day & 
1/3 to ½ diaper on next day 
 
10 
Scanty - One diaper on one day and 1/3 to 
1/2diaper on next day  
 
05 
Slightly less than normal – one to two 
diapers for two consecutive days 
 
02 
Normal – one or two diaper each for at 
least two consecutive days 
 
00 
2. Duration of Flow 
One day 20 
Two days 10 
Three days 05 
Four days 02 
Five days 00 
3. Pain in abdomen 
Very severe – Regular and frequent 
intake of analgesics / antispasmodics 
and are always bedridden 
 
 
20 
Severe – Needs often analgesics / 
antispasmodics and force to take rest 
 
10 
Moderate – Pain needs analgesics or rest 05 
Mild – Presence of pain abdomen but do 
not need analgesic / antispasmodic and 
pain do not limit their physical activity 
 
 
02 
No Pain 00 
4. Status of PCOD on USG 
Presence of bilateral PCOD 40 
Absence of bilateral PCOD 00 
OBSERVATIONS 
Demographic data 
Table 1. Showing the incidence of age 
Age in years No of cases Percentage 
13 years 02 03.85 
14 years 07 13.46 
15 years 09 17.30 
16 years 14 26.92 
17 years 00 00.00 
18 years 11 21.16 
19 years 09 17.31 
Total 52 100 
Table 2. Showing the incidence of Body built 
Type Number Percentage 
Heavy 33 63.46 
Medium 13 25.00 
Lean 06 11.54 
Total 52 100 
Table 3. Showing the Incidence of Prakriti 
  V P K Vata 
Pitta 
Pitta 
Kapha 
Vata 
Kapha 
Sama Total 
No - - - 17 12 23 - 52 
% - - - 32.69 23.07 44.24 - 100 
V-Vata; P-Pitta; K-kapha 
Table 4. Incidence of Occupation 
  House 
wife 
Desk 
work 
Labour Field 
work 
Total 
No 03 36 02 11 52 
% 05.76 69.24 03.84 21.16 100 
 
Table 5. Showing incidence of Education 
 Number Percentage 
Illiterate 00 00.00 
Primary school 04 07.69 
Middle school 08 15.39 
High school 04 07.69 
College 29 55.77 
Professional 07 13.46 
Total 52 100 
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CLINICAL DATA 
Table 6. Changes in duration of menstrual flow 
before & after treatment 
Duration of 
menstrual 
flow 
Before 
treatment 
After treatment 
No Percentage No  Percentage 
1 day 17 34.69 02 04.08 
2 days 06 12.25 01 02.04 
3 days 19 38.77 22 44.89 
4 days 01 02.04 08 16.34 
5 days 06 12.25 16 32.65 
Total 49 100 49 100 
Table 7. Changes in amount of menstrual flow 
before & after treatment 
Amount of 
menstrual flow 
Before 
treatment 
After 
treatment 
No  Percentage No  Percentage 
Spotting 10 20.40 00 00.00 
Very scanty 08 16.33 00 00.00 
Scanty 27 55.10 11 22.45 
Slightly <normal 04 08.17 06 12.25 
Normal 00 00.00 32 65.30 
Total 49 100 49 100 
Table 8. Changes in pain abdomen during 
menstruation before & after treatment 
Pain 
Abdomen 
Before 
treatment 
After treatment 
No  Percentage No Percentage 
Mild 21 42.86 16 32.65 
Moderate 09 18.37 10 20.41 
Severe 12 24.49 07 14.29 
Very severe 02 04.08 00 00.00 
No pain 05 10.20 16 32.65 
Total 49 100 49 100 
Table 9. Changes in consistency of menstrual 
blood before & after treatment 
Consistency of 
menstrual 
blood 
Before 
treatment 
After treatment 
No Percentage No Percentage 
Normal 23 46.94 33 67.35 
Clotted 16 32.65 08 16.33 
Thin 07 14.29 06 12.25 
Mucoid 03 06.12 02 04.08 
Total 49 100 49 100 
 
 
Table 10. Changes in PCOD on USG before and 
after treatment 
Bilateral 
PCOD 
Before 
treatment 
After 
treatment 
Number % Number % 
Present 49 100.00 33 67.34 
Absent 00 00.00 16 32.66 
Total 49 100 49* 100 
*Drop outs not calculated for responses 
Table 11. Results of the study 
  GR FR PR NR Total 
Number 21 10 03 15 49* 
Percentage 42.86 20.41 06.12 32.61 100 
* Drop outs not calculated for responses 
Table 12. Statistical analysis of efficacy of trial 
drug on over all parameters 
 Before 
treatment 
After 
treatment 
Difference 
Mean 98.28 31.71 68.65 
SD 14.85 26.84 31.32 
SE 2.80 5.07 5.29 
-t   12.96 
P   <0.001 
 DISCUSSION 
Present study carried out to evaluate 
clinically Ashokarishtam, Varunadikashayam and 
Kanchanara Guggulu in teenage Poly cystic ovarian 
disease cases. A total of 52 cases were studied; of 
which 21 (42.86%) patients have shown Good 
response, 10 (20.41%) cases have shown Fair 
response, 03 (06.12%) cases have shown Poor 
response, 15 (32.61%) did not show any response 
and 03 cases were dropped out from the study.  
In Ashokarishta, Ashoka (Saraca asoka) is 
the main ingredient. It is having stimulating 
activity on the endometrium, ovary. It is 
containing phenolic-glycoside and non-phenolic 
glycoside. Phenolic glycoside exhibited spasmodic 
action on smooth muscles due to direct myotropic 
action. Spasmodic action of phenolic glycoside on 
uterus was not blocked by pentolinium and 
atropine. Pure phenolic glycoside is non-toxic in 
nature. It is having pharmacological activities like 
astringent, anti-tumor, anti-fungal, antifertility, 
spasmodic action in uterine affections etc[10].  
In Varunadi kashayam, Varuna 
(Crataeva nurvala Sensu Kanj. & Das) is the main 
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ingredient. Varuna is Kaphavata samaka, 
Pittavardhaka, Bhedana, Krimighna, Gulmahara, 
Jvaraghna properties. The drug is having 
pharmacological properties like anti-
inflammatory, anti-arthritic, antipyretic, 
antibacterial effects. Aqueous extract of air dried 
bark was shown spasmodic action on uteri of rats, 
rabbits, guinea pigs, dogs and human beings and 
cholinergic action on isolated ileum of rabbit, 
guinea pig and rat[11]. 
In Kanchanara Guggulu, Kanchanara 
(Bauhinia variegate) and Guggulu (Commiphora 
wightii) are the main ingredients. Kanchanara is 
having Sothahara, Grandhihara, Kaphahara, 
Vranasodhaka etc properties. Kanchanara bark 
showed significant anti-inflammatory activity. The 
petroleum ether, benzene, chloroform and alcohol 
extracts did not show any toxicity either orally or 
intraperitonially. It is found effective in goiter. It is 
probably having some thyroid hormone-like 
activity in addition to iodine contents which might 
be responsible for neutralizing the thyroid gland 
both morphologically as well as functionally[12]. 
 Guggulu is having Sothahara, 
Srothorodhahara, Vranaprakshalana, Lekhana, 
Rasayana, Saraka, Raktasodhaka, Tridoshaghna 
properties. Gum resin showed different 
pharmacological properties like astringent, 
aphrodisiac, antispasmodic, emmenagogue, 
thyroid stimulating, hypolipidaemic, 
hypocholesteraemic activities[13]. 
CONCLUSIONS 
1. PCOD or Stien leventhal syndrome is the 
commonest problem seen in teenage girls. 
2. Most of the times it manifests as 
oligomenorrhoea or amenorrhoea or delayed 
and irregular periods along with hirsutism, 
hoarseness of voice, obesity etc. 
3. This complex disorder is characterized by 
excessive androgen production by the ovaries / 
adrenals which interfere with ripening of 
ovarian follicles. 
4. Modern medicine gynecologists give treatment 
with combined hormonal pills to regularize 
periods, but it will further disturb the 
endogenous hormonal pattern. 
5. In Ayurveda, drugs having emmenagogue 
property are available in plenty and drugs also 
having fibrolytic activity are also available. 
6. Based on previous studies and properties 
Ashokarishtam, Kanchanara guggulu and 
Varunadi kashayam are selected for the study. 
7. Study carried out in 52 number of cases; of 
which 21 (42.86%) patients have shown Good 
response, 10 (20.41%) cases have shown Fair 
response, 03 (06.12%) cases have shown Poor 
response, 15 (32.61%) did not show any 
response and 03 cases were dropped out from 
the study. 
8. On statistical analysis, efficacy of the trial drugs 
is found highly significant in relieving PCOD 
(P<0.001). 
9. Ashokarishta is having stimulating activity on 
the endometrium, ovary and containing 
phenolic-glycoside and non-phenolic 
glycosides. It might have acted through these 
ingredients in the regularization of 
menstruation and improvement in menstrual 
blood. 
10. Varunadikashayam and Kanchanara guggulu 
are well proved fibrolytic drugs and hence 
both might have worked in synergy in curing 
the follicular cysts.  
ACKNOWLEDGEMENTS 
The Authors are grateful to Director, 
CCRAS and Project Officer, ALRCA for their 
encouragement. Authors are also thankful to Smt. 
E. Nagalakshmi, Senior Stenographer for her 
typographical help. 
REFERENCES 
1. Keith Eamonds, Dewhursts’s Textbook of 
Obstetrics and Gynecology, 7th edition, 
Blackwell publishing, Oxford university 
press, 2007, Pp. 381-387 
2. John stud, Progress in Obstetrics & 
Gynecology, vol-11, B.I. Churchill Livingston 
pvt. Ltd., New Delhi, 1996, Pp. 351-370 
3. Pratap kumar and Narendra Malhotra, 
Jeffcoate’s Principles of Gynecology, 7th 
edition, Jaypee publishers, New Delhi, 2008, 
Pp. 385-393. 
4. Tewari, P.V, Ayurvediya Prasutitantra evam 
Streee roga, Part-II, Chowkhambha 
Orientalia, Varanasi, 1986, Pp 163-167. 
5. Malhotra, Pharmacological investigations of 
certain Medicinal plants & compound 
formulations used in Ayurveda& Siddha, 
CCRAS, New Delhi, 1996, Pp. 30-33. 
 Int. J. Ayur. Pharma Research, 2013; 1(3): 30-35                        ISSN 2322 - 0910 
 
                                                                           Available online at : http://ijapr.in Page 35 
6. Ibid; Pp. 163-165 and 123-126. 
7. Ambikadatta sastri, Bhaisajyaratnavali, 
Vidyotini hindi commentary, Chowkhambha 
Sanskrit Series Office, Varanasi, Pp. 720, 
1951 
8. Ibid; Pp. 583. 
9. Ibid; Pp. 502, 1951. 
10. Malhotra, Pharmacological investigations of 
certain Medicinal plants & compound 
formulations used in Ayurveda& Siddha, 
CCRAS, New Delhi, 1996, Pp. 30-33. 
11. Ibid; Pp. 363-365. 
12. Ibid; Pp.163-165. 
13. Ibid; Pp. 123-126. 
 
*Address for correspondence 
Dr. K. Bharathi  
Research officer (Ayu.) 
Scientist -3 
National Institute of Indian Medical 
Heritage, Survey No. 314 
Revenue Board Colony 
Gaddiannaram, Hyderabad - 500036 
Andhra Pradesh, India. 
Cell: +919492047131 
Email: baruhunt@rediffmail.com  
 
Cite this article as:  
K. Bharathi, C.M. Jain, B. Pushpalatha. Evaluation of 
Indigenous Drugs in the Management of PCOD in Teenage 
Girls. Int. J. Ayur. Pharma Research 2013; 1 (3): 30-35 
Source of support: Nil, Conflict of interest: None Declared 
 
